10-K/A: DT Cloud Star Files 10-K/A, Details PrimeGen Merger

DT Cloud Star Acquisition Corporation filed an amendment to its 2025 Annual Report, confirming a pending business combination with PrimeGen US, Inc.

Summary

• DT Cloud Star Acquisition Corporation is a blank check company that has entered into a Business Combination Agreement (BCA) with PrimeGen US, Inc. on February 2, 2026.
• The company reported net income of $2,132,715 for the fiscal year ended December 31, 2025, primarily driven by interest earned on the trust account.
• As of December 31, 2025, the company had a working capital deficit of $361,245 and cash of $461.
• The company has extended its deadline to complete a business combination to October 26, 2026.
• A total of 5,247,491 shares were tendered for redemption during the year, significantly impacting liquidity.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as neutral; while the company has entered into a definitive business combination agreement, it faces significant liquidity challenges and going concern risks.

Positives

• Successful execution of a Business Combination Agreement with PrimeGen US, Inc. valued at approximately $1.49 billion.
• Management has secured extensions to the business combination deadline, providing additional time to finalize the transaction.
• The company has successfully generated interest income from the trust account to support operations.

Negatives

• The company reported a working capital deficit of $361,245 as of December 31, 2025.
• Substantial doubt exists regarding the company's ability to continue as a going concern if the business combination is not consummated.
• Significant redemptions of public shares have reduced the cash available for operations and the potential business combination.

Risks

• The company is a blank check entity with no operating history and no revenue prior to the business combination.
• Failure to consummate the business combination by October 26, 2026, will result in mandatory liquidation.
• The company may be subject to U.S. foreign investment regulations, including potential CFIUS review, due to the sponsor's ownership structure.
• Potential regulatory intervention by the PRC government given the sponsor's ties to China.
• The company may be unable to obtain additional financing if required to complete the business combination.

Future Outlook

The company intends to consummate the business combination with PrimeGen US, Inc. and is actively working to satisfy the closing conditions, including regulatory and shareholder approvals.

Management Comments

• Management believes that the consummation of the proposed business combination would provide an operating business and additional capital resources.
• Management is actively managing cash resources to ensure sufficient funds are available to meet the minimum cash condition required to consummate the business combination.

Industry Context

StockSavvy.ai notes that this filing reflects the ongoing trend of SPACs utilizing extensions and private financing to navigate the challenging environment for completing business combinations, particularly for those with cross-border exposure.

Comparison to Industry Standards

• The company's structure as a Cayman Islands-incorporated SPAC is standard for the industry.
• The use of extensions and promissory notes from sponsors is a common practice among SPACs facing liquidity constraints prior to a business combination.
• The 80% fair market value requirement for the target business is consistent with Nasdaq listing rules for SPACs.

Corporate Governance

Legal Proceedings

• None.

Related Party Transactions

• Promissory notes issued to the sponsor for working capital and trust account extensions.
• Administrative services agreement with an affiliate of the sponsor for $10,000 per month.

Stakeholder Impact

• Shareholders face potential dilution from the issuance of shares in the business combination.
• Public shareholders have redemption rights if they do not support the business combination.

Next Steps

• Obtain shareholder approval for the business combination.
• Satisfy all closing conditions stipulated in the Business Combination Agreement.
• Continue to manage liquidity and potentially issue additional promissory notes to the sponsor.

Key Dates

Recommendation

The stock is a speculative play on the successful completion of the PrimeGen US merger. Investors should hold until more clarity on the closing timeline and potential dilution is provided.

Keywords

SPAC, Business Combination, PrimeGen US, DT Cloud Star, Merger, IPO, Nasdaq